KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Asset Writedowns and Impairment: 2009-2020

Historic Asset Writedowns and Impairment for Chemed (CHE) over the last 10 years, with FY2020 value amounting to $657000.0.

  • Chemed's Asset Writedowns and Impairment changed N/A to -$443000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $204000.0, marking a year-over-year change of. This contributed to the annual value of $657000.0 for FY2020, which is N/A changed from last year.
  • As of FY2020, Chemed's Asset Writedowns and Impairment stood at $657000.0.
  • In the past 5 years, Chemed's Asset Writedowns and Impairment ranged from a high of $17.3 million in FY2017 and a low of $657000.0 during FY2020
  • Over the past 3 years, Chemed's median Asset Writedowns and Impairment value was $16.3 million (recorded in 2016), while the average stood at $11.4 million.
  • Per our database at Business Quant, Chemed's Asset Writedowns and Impairment soared by 1454.34% in 2016 and then soared by 604.82% in 2017.
  • Over the past 3 years, Chemed's Asset Writedowns and Impairment (Annual) stood at $16.3 million in 2016, then rose by 6.05% to $17.3 million in 2017, then tumbled by 96.2% to $657000.0 in 2020.
  • Its Asset Writedowns and Impairment stands at $657000.0 for FY2020, versus $17.3 million for FY2017 and $16.3 million for FY2016.